-
公开(公告)号:EP3302035B1
公开(公告)日:2023-10-25
申请号:EP16729434.7
申请日:2016-05-31
IPC分类号: A01H5/10 , C07K14/415
-
-
公开(公告)号:EP3207076B1
公开(公告)日:2023-06-28
申请号:EP15849912.9
申请日:2015-10-16
发明人: MENTAK, Khalid
IPC分类号: C08G61/10 , C08L65/00 , C08K5/00 , C08F220/18 , C08F220/30 , G02B1/04 , A61F2/16
-
公开(公告)号:EP3603544B1
公开(公告)日:2023-05-10
申请号:EP19193930.5
申请日:2016-05-27
发明人: AVNERI, Shahar , AVNERI, Itzhak , LORE, Rami , YUVAL, Gonen
IPC分类号: A61B17/221 , A61B17/3205
-
公开(公告)号:EP3253222B1
公开(公告)日:2022-06-22
申请号:EP16747181.2
申请日:2016-02-03
-
6.
公开(公告)号:EP4008333A1
公开(公告)日:2022-06-08
申请号:EP21205379.7
申请日:2019-02-19
发明人: MICOL, Romain
IPC分类号: A61K31/7088 , C12N15/11 , A61K48/00
摘要: Provided is an isolated mRNA sequence for expression of one or more cytokines within one or more target organs, the sequence comprising at least one coding sequence which codes for one or more cytokines (or their ligands) involved in immune response and inflammation selected from one or more of: TNFα, TNFβ, IFNα, IFNβ, IFNgamma, IL1, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL11, IL12, CCL2, CCL3, CCL4, CCL5, CXCL 9, and CXCL10. The sequence also comprises at least a first untranslated region (UTR) sequence, and at least three different micro-RNA (miRNA) binding site sequences. Each of the miRNA binding site sequences is located within, immediately 5' to or immediately 3' to, the first UTR sequence; and the miRNA binding site sequences allow for differential expression of the coding sequence in at least a first and a second cell type within the target organ or organs. Also provided are pharmaceutical compositions comprising the mRNA sequence, and methods for using the sequence or composition, particularly in treatment of disease, such as cancer of the liver, brain, lung, breast, pancreas, colon and kidney.
-
-
-
公开(公告)号:EP2954108B1
公开(公告)日:2022-04-06
申请号:EP14707840.6
申请日:2014-02-08
-
公开(公告)号:EP3145583B1
公开(公告)日:2022-03-02
申请号:EP15727213.9
申请日:2015-05-21
-
-
-
-
-
-
-
-
-